Candidate Neisseria meningitidis NspA vaccine
- PMID: 11000456
- DOI: 10.1016/s0168-1656(00)00294-7
Candidate Neisseria meningitidis NspA vaccine
Abstract
The highly conserved NspA protein has been found in the outer membrane of every Neisseria meningitidis strain tested so far. Two monoclonal antibodies (MAbs) directed against this protein were used to demonstrate that biologically important epitopes of the NspA protein are exposed at the surface of serologically distinct meningococcal strains. Analysis of sera collected from mice that survived a deadly meningococcal challenge following immunization with recombinant NspA protein (rNspA) revealed the presence of cross-reactive antibodies which efficiently attached to and killed the four serogroup B strains tested. These data are additional proof that the NspA protein is exposed at the surface of intact meningococcal cells, which is an important characteristic for a vaccine candidate.
Similar articles
-
Differences in surface expression of NspA among Neisseria meningitidis group B strains.Infect Immun. 1999 Nov;67(11):5664-75. doi: 10.1128/IAI.67.11.5664-5675.1999. Infect Immun. 1999. PMID: 10531214 Free PMC article.
-
Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.Infect Immun. 2001 Jun;69(6):3762-71. doi: 10.1128/IAI.69.6.3762-3771.2001. Infect Immun. 2001. PMID: 11349041 Free PMC article.
-
Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.J Exp Med. 1997 Apr 7;185(7):1173-83. doi: 10.1084/jem.185.7.1173. J Exp Med. 1997. PMID: 9104804 Free PMC article.
-
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.Contrib Microbiol Immunol. 1989;10:151-65. Contrib Microbiol Immunol. 1989. PMID: 2479499 Review. No abstract available.
-
Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine.J Med Microbiol. 1996 Apr;44(4):237-43. doi: 10.1099/00222615-44-4-237. J Med Microbiol. 1996. PMID: 8606350 Review.
Cited by
-
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.Infect Immun. 2002 Nov;70(11):6021-31. doi: 10.1128/IAI.70.11.6021-6031.2002. Infect Immun. 2002. PMID: 12379678 Free PMC article.
-
Phenotypic and transcriptional characterization of the meningococcal PhoPQ system, a magnesium-sensing two-component regulatory system that controls genes involved in remodeling the meningococcal cell surface.J Bacteriol. 2005 Jul;187(14):4967-75. doi: 10.1128/JB.187.14.4967-4975.2005. J Bacteriol. 2005. PMID: 15995212 Free PMC article.
-
Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B.Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9542-7. doi: 10.1073/pnas.1033001100. Epub 2003 Jul 25. Proc Natl Acad Sci U S A. 2003. PMID: 12883001 Free PMC article.
-
The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.PLoS Pathog. 2010 Jul 29;6(7):e1001027. doi: 10.1371/journal.ppat.1001027. PLoS Pathog. 2010. PMID: 20686663 Free PMC article.
-
From empiricism to rational design: a personal perspective of the evolution of vaccine development.Nat Rev Immunol. 2014 Jul;14(7):505-14. doi: 10.1038/nri3694. Epub 2014 Jun 13. Nat Rev Immunol. 2014. PMID: 24925139 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources